August 8 is National CBD Day 2022
In honor of National CBD Day, Psychiatric Times™ shares some recent expert discussions on the pros, cons, and clinical implications of cannabis use in psychiatry.
Cannabis Legalization: What Psychiatrists Need to Know
Samantha Johnstone, BA; Kevin P. Hill, MD, MHS; and Tony P. George, MD, FRCPC, provide an update on cannabis legislation and its clinical utility.
Ms Johnstone is a research analyst at the Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada. Dr Hill is an associate professor of psychiatry at Harvard Medical School, and director of addiction psychiatry at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. Dr George is professor of psychiatry, Temerty Faculty of Medicine, at the University of Toronto, and senior physician-scientist at CAMH in Toronto, Ontario, Canada. He is currently deputy editor and incoming coprincipal editor of Neuropsychopharmacology (NPP).
John J. Miller, MD, shares 10 keys to understanding the science of cannabinoids.
Dr Miller is medical director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric TimesTM; staff psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Exeter Hospital, Exeter; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Clinical Management of Cannabis Complications
Thomas R. Kosten, MD, and Christopher D. Verrico, PhD, discuss the psychiatric challenges posed by cannabinoids and their clinical implications.
Dr Kosten is the Jay H. Waggoner Endowed Chair and co-founder at the Institute for Clinical and Translational Research. He is also a professor of psychiatry, neuroscience, pharmacology, and immunology at Baylor College of Medicine in Houston, Texas. Dr Verrico is an assistant professor of psychiatry research at Baylor College of Medicine.
The Age of Cannabis Has Arrived: Issues for Older Adults
Marc E. Agronin, MD, weighs in on the effects of cannabis use in older patients.
Dr Agronin is the chief medical officer at MIND Institute at Miami Jewish Health.
Cannabis is prescribed as a treatment for autism in several states—is it the wonder drug patients and families have been waiting for? Rashmi Parmar, MD, weighs in.
Dr Parmar is a double board-certified adult and child psychiatrist with Community Psychiatry based in Newark CA. She earned her medical degree at Terna Medical College & Hospital in Mumbai, India.
How to Discuss Cannabis With Your Patients
Tony Thrasher, DO, DFAPA, shares how to effectively approach the topic of cannabis use with your patients.
Dr Thrasher is the president of the American Association for Emergency Psychiatry (AAEP) and the medical director of crisis services in Milwaukee County, Wisconsin.